At a hotel in central Warsaw, hundreds of public health experts, consumer advocates for safer nicotine alternatives, industry representatives and drug policy reformers from across the world gathered to discuss the fact, as the event’s tagline had it, that tobacco harm reduction (THR) is “here for good.”
For a few days in mid-June, at the annual Global Forum on Nicotine (GFN), these stakeholders grappled with the many imperfections of this ostensibly cheering reality.
They spent dozens of hours in panels and side meetings, and loitering in the halls of the Marriott, swapping ideas on how to change public and political perceptions of e-cigarettes and other nicotine options that are much less harmful than smoking.
“Yes, tobacco harm reduction is here for good. But for how many people?”
“Yes, tobacco harm reduction is here for good,” Dr. Konstantinos Farsalinos, a leading THR researcher at the University of Patras and the School of Public Health-University of West Attica in Greece, said in one plenary discussion. “But for how many people?”
Alex Norcia – Filter – 2022-06-24.
Want More Investigative Content?
